<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45">
 <label>45.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kester</surname>
    <given-names>KE</given-names>
   </name>
   <name>
    <surname>Cummings</surname>
    <given-names>JF</given-names>
   </name>
   <name>
    <surname>Ofori-Anyinam</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Ockenhouse</surname>
    <given-names>CF</given-names>
   </name>
   <name>
    <surname>Krzych</surname>
    <given-names>U</given-names>
   </name>
   <name>
    <surname>Moris</surname>
    <given-names>P</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection</article-title>. 
  <source>J Infect Dis.</source> (
  <year>2009</year>) 
  <volume>200</volume>:
  <fpage>337</fpage>â€“
  <lpage>46</lpage>. 
  <pub-id pub-id-type="doi">10.1086/600120</pub-id>
  <?supplied-pmid 19569965?>
  <pub-id pub-id-type="pmid">19569965</pub-id>
 </mixed-citation>
</ref>
